Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 May 2008:
Vol. 320. no. 5877, pp. 749 - 750
DOI: 10.1126/science.1153843
Prev | Table of Contents | Next

Policy Forum

PUBLIC HEALTH:
Reassessing HIV Prevention

Malcolm Potts,1* Daniel T. Halperin,2*† Douglas Kirby,3 Ann Swidler,4 Elliot Marseille,5 Jeffrey D. Klausner,6 Norman Hearst,7 Richard G. Wamai,2 James G. Kahn,5 Julia Walsh1

The largest investments in AIDS prevention targeted to the general population are being made in interventions where the evidence for large-scale impact is uncertain.

1School of Public Health, University of California at Berkeley, Berkeley, CA 94720, USA.

2Harvard University School of Public Health, Boston, MA 02115, USA.

3ETR Associates, Scotts Valley, CA 95066, USA.

4Department of Sociology, University of California at Berkeley, Berkeley, CA 94720, USA.

5Philip R. Lee Institute for Health Policy Studies, University of California at San Francisco, San Francisco, CA 94143, USA.

6San Francisco Department of Public Health, San Francisco, CA 94103, USA.

7Department of Family and Community Medicine, University of California at San Francisco, San Francisco, CA 94143, USA.

*These authors contributed equally to this work.

†Author for correspondence. E-mail: daniel_halperin{at}harvard.edu

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products